Stock Events

Arrowhead Pharmaceuticals (A2RR34.SA) Q3 2018 Earnings

7AugConfirmed
Q4 2017
Q1 2018
Q2 2018
Q3 2018
-0.68
-0.55
-0.42
-0.3

Details

Expected EPS
-0.675036
Actual EPS
-0.675036
Surprise EPS
0
Surprise Percent
+0%

Description

Arrowhead Pharmaceuticals (A2RR34.SA) has reported earnings of -0.675036 per share for Q3 2018.

0 Comments

Share your thoughts